Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2025-09-29 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - AVR 9 pages 27.8KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and contains detailed information about securities that have ceased, including ASX security codes, descriptions, numbers of securities ceased, reasons for cessation, and dates. It is a formal announcement notifying the market and regulatory bodies about the cessation (expiry or lapse) of certain securities. There is no financial performance data, management discussion, or audit information. The document is not a report but an official notification of changes in securities status. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-09-29 English
DEFA14A
Regulatory Filings
2025-09-19 English
8-K
Regulatory Filings
2025-09-19 English
Special Meeting - Adjourned 1 page 152.5KB
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the adjournment of a Special Meeting of Stockholders. It provides details about the meeting's postponement and states that further details will be provided later. There is no financial data, no detailed report, no voting results, no management discussion, or other substantive content typical of financial reports. The document is short (3005 characters) and serves as a notification about the meeting status rather than the meeting materials or results. Therefore, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous announcements that do not fit other specific categories.
2025-09-18 English
Adjournment of Special Meeting of Stockholders - Update 3 pages 184.1KB
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the adjournment of a Special Meeting of Stockholders due to lack of quorum. It provides details about the rescheduled meeting date, voting instructions, and references the definitive Proxy Statement filed with the SEC on August 18, 2025. The document does not contain any financial statements, management discussion, or detailed report content. It primarily serves as a notice updating shareholders about the meeting status and voting process. Therefore, it is best classified as a Proxy Solicitation & Information Statement (PSI) related announcement or update, but since it is an adjournment notice and not the Proxy Statement itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement. The document length (7981 characters) and content confirm it is not a brief report publication announcement but a substantive regulatory update. Hence, the classification is Regulatory Filings (RNS) with high confidence.
2025-09-18 English
Postponement of Special Meeting - Update 3 pages 184.6KB
Regulatory Filings Classification · 95% confidence The document is a public announcement from Anteris Technologies Global Corp. regarding the postponement of a Special Meeting of Stockholders. It references the Proxy Statement filed with the SEC on August 18, 2025, and provides details about voting deadlines and procedures. The document does not contain financial statements, audit information, or detailed management discussion. It is primarily an update about the scheduling and voting process for a shareholder meeting, not the meeting materials themselves or voting results. Therefore, it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement related to shareholder meeting logistics and does not fall into more specific categories like Proxy Solicitation (PSI) or Declaration of Voting Results (DVA). The document length and content confirm it is not a brief announcement but a detailed notice, yet it is not a full report or financial filing.
2025-09-11 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.